Heart failure prognostic models why bother?

Circulation: Heart Failure

Volumn 5, Issue 1, 2012, Pages 6-9

  Aaronson, Keith D ^a   Cowger, Jennifer ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CARDIOPULMONARY EXERCISE TEST; DISEASE SEVERITY; HEART ASSIST DEVICE; HEART FAILURE; HEART HEMODYNAMICS; HEART INDEX; HEART TRANSPLANTATION; HOSPITALIZATION; HUMAN; MORTALITY; OBESITY; PATIENT INFORMATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SURVIVAL RATE; SYSTOLIC HEART FAILURE; TREADMILL EXERCISE; FEMALE; HEART LEFT VENTRICLE FUNCTION; MALE; NOTE; STATISTICAL MODEL;

FEMALE; HEART FAILURE; HUMANS; MALE; MODELS, STATISTICAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84859635779     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.111.965848     Document Type: Review

References (23)

1. Andersson B, Sylven C. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol. 1996;28:162-167. (Pubitemid 26266636)
2. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;121: 2331-2378.
3. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 2005;45:969-981. (Pubitemid 40432425)
4. McNamara DM, Holubkov R, Janosko K, Palmer A, Wang JJ, MacGowan GA, Murali S, Rosenblum WD, London B, Feldman AM. Pharmacogenetic interactions between beta-blocker therapy and the angiotensin- converting enzyme deletion polymorphism in patients with congestive heart failure. Circulation. 2001;103:1644-1648. (Pubitemid 32246611)
5. Nair N, Farmer C, Gongora E, Dehmer GJ. Commonality between depression and heart failure. Am J Cardiol. Published online before print December 5, 2011. doi:10.1016/j.amjcard.2011.10.039. http://www. sciencedirect.com/science/ article/pii/S0002914911032139. Accessed December 15, 2011.
6. Keenan PS, Normand SL, Lin Z, Drye EE, Bhat KR, Ross JS, Schuur JD, Stauffer BD, Bernheim SM, Epstein AJ, Wang Y, Herrin J, Chen J, Federer JJ, Mattera JA, Krumholz HM. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008;1:29-37.
7. Levy WC, Lee KL, Hellkamp AS, Poole JE, Mozaffarian D, Linker DT, Maggioni AP, Anand I, Poole-Wilson PA, Fishbein DP, Johnson G, Anderson J, Mark DB, Bardy GH. Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure population. Circulation. 2009;120:835-842.
8. Levy WC, Mozaffarian D, Linker DT, Farrar DJ, Miller LW, Investigators R. Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy? J Heart Lung Transplant. 2009;28:231-236.
9. Prasad H, Sra J, Levy WC, Stapleton DD. Influence of predictive modeling in implementing optimal heart failure therapy. Am J Med Sci. 2011;341:185-190.
10. Clarke M, Shah A, Sharma U. Systematic review of studies on telemonitoring of patients with congestive heart failure: A meta-analysis. J Telemed Telecare. 2011;17:7-14.
11. Allen LA, Yager JE, Funk MJ, Levy WC, Tulsky JA, Bowers MT, Dodson GC, O'Connor CM, Felker GM. Discordance between patientpredicted and model-predicted life expectancy among ambulatory patients with heart failure. JAMA. 2008;299:2533-2542. (Pubitemid 351787209)
12. President's Commission for the Study of Ethical Problems in Medicine and Biomedical Research. Making Health Care Decisions. Washington, DC: US Government Printing Office; 1982.
13. Fetters MD, Masuda Y. Japanese patients' preferences for receiving cancer tests results while in the United States: Introducing an advanced care directive for cancer disclosure. J Palliat Med. 2000;3:361-374.
14. Parascandola M, Hawkins J, Danis M. Patient autonomy and the challenge of clinical uncertainty. Kennedy Inst Ethics J. 2002;12: 245-264.
15. Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation. 1997;95:2660-2667. (Pubitemid 27255495)
16. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, Anand I, Maggioni A, Burton P, Sullivan MD, Pitt B, Poole-Wilson PA, Mann DL, Packer M. The Seattle Heart Failure Model: Prediction of survival in heart failure. Circulation. 2006;113:1424-1433. (Pubitemid 43739439)
17. Aaronson KD, Mancini DM. Risk factors for mortality with heart failure. In: Kormos RL, Miller LW, eds. Mechanical Circulatory Support: A Companion to Braunwald's Heart Disease. Philadelphia, PA: Elsevier Saunders; 2012:56-71.
18. O'Connor CM, Whellan DJ, Wojdyla D, Leifer E, Clare RM, Ellis SJ, Fine LJ, Fleg JL, Zannad F, Keteyian SJ, Kitzman DW, Kraus WE, Rendall D, Piña IL, Cooper LS, Fiuzat M, Lee KL. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: The HF-ACTION Predictive Risk Score Model. Circ Heart Fail. 2012;5:63-71.
19. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ, Leifer ES, Kraus WE, Kitzman DW, Blumenthal JA, Rendall DS, Miller NH, Fleg JL, Schulman KA, McKelvie RS, Zannad F, Piña IL; HF-ACTION Investigators. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1439-1450.
20. Gorodeski EZ, Chu EC, Chow CH, Levy WC, Hsich E, Starling RC. Application of the Seattle Heart Failure Model in ambulatory patients presented to an advanced heart failure therapeutics committee. Circ Heart Fail. 2010;3:706-714.
21. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross H, Fowler MB. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med. 1998;129:286-293. (Pubitemid 28394573)
22. Hsich E, Gorodeski EZ, Starling RC, Blackstone EH, Ishwaran H, Lauer MS. Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction. Circulation. 2009;119:3189-3197.
23. Harrell FE Jr, Lee KL, Califf RM, Pryor DB, Rosati RA. Regression modelling strategies for improved prognostic prediction. Stat Med. 1984;3:143-152. (Pubitemid 14052973)